Baytril 100-CA1
Injectable enrofloxacin solution for the treatment of clinical anaplasmosis in cattle
Baytril 100-CA1
Injectable enrofloxacin solution for the treatment of clinical anaplasmosis in cattle
Product description
Baytril 100-CA1 is an injectable solution prescribed for the treatment of clinical anaplasmosis in cattle. Anaplasmosis is a vector-borne, infectious blood disease usually spread by ticks. The tick transmits the bacteria, which infects red blood cells and cause severe anemia. Anemia is a condition in which your cattle lack enough healthy red blood cells to carry adequate oxygen to their body's tissues. The first signs of anaplasmosis are anemia and weakness. Cattle will also have difficulties eating and drinking. The active ingredient in Baytril 100-CA1 is enrofloxacin, which is a powerful antibiotic that kills the bacteria by interfering with the creation of its DNA.
Active ingredients
Each ml of Baytril 100-CA1 contains 100 mg of enrofloxacin.
Inactive Ingredients: 200 mg of L-arginine base, 30 mg of n-butyl alcohol, 20 mg benzyl alcohol (as a preservative), and water for injection.
Indications for use
Baytril 100-CA1 Antimicrobial Injectable Solution (enrofloxacin) is indicated for the treatment of clinical anaplasmosis associated with Anaplasma marginale in replacement dairy heifers under 20 months of age and all classes of beef cattle except beef calves less than 2 months of age and beef bulls intended for breeding (any age). Not for use in any other class of dairy cattle or in veal calves.
Administration and dosage
Baytril 100-CA1 should be administered as a single dose for treatment of clinical anaplasmosis. Administer, by subcutaneous injection, a single dose of 12.5 mg/kg of body weight (5.7 mL/100 lb). Administered dose volume should not exceed 20 mL per injection site.
See the dosing table in the pdf located in the prescribing information section.